skip to main content
Idioma:
Sua busca inicial resultou em poucos registros ou nenhum resultado. Os resultados abaixo foram encontrados ao expandir sua busca.
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Handbook of cancer chemotherapy
Handbook of cancer chemotherapy
Material Type:
Livro 		Adicionar ao Meu Espaço

Handbook of cancer chemotherapy

Roland T Skeel

Philadelphia Lippincott Williams & Wilkins c1999

Localização: FM - Fac. Medicina    (QZ39 H21 5.ed. 1999 )(Acessar)

2
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Johnston, Stephen R D ; Harbeck, Nadia ; Hegg, Roberto ; Toi, Masakazu ; Martin, Miguel ; Shao, Zhi Min ; Zhang, Qing Yuan ; Martinez Rodriguez, Jorge Luis ; Campone, Mario ; Hamilton, Erika ; Sohn, Joohyuk ; Guarneri, Valentina ; Okada, Morihito ; Boyle, Frances ; Neven, Patrick ; Cortés, Javier ; Huober, Jens ; Wardley, Andrew ; Tolaney, Sara M ; Cicin, Irfan ; Smith, Ian C ; Frenzel, Martin ; Headley, Desirée ; Wei, Ran ; San Antonio, Belen ; Hulstijn, Maarten ; Cox, Joanne ; O'Shaughnessy, Joyce ; Rastogi, Priya

Journal of clinical oncology, 2020-12, Vol.38 (34), p.3987-3998 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

James, Nicholas D, Prof ; Sydes, Matthew R, MSc ; Clarke, Noel W, Prof ; Mason, Malcolm D, Prof ; Dearnaley, David P, Prof ; Spears, Melissa R, MSc ; Ritchie, Alastair W S, MD ; Parker, Christopher C, MD ; Russell, J Martin, FRCR ; Attard, Gerhardt, MD PhD ; de Bono, Johann, Prof ; Cross, William, PhD ; Jones, Rob J, Prof ; Thalmann, George, Prof ; Amos, Claire, PhD ; Matheson, David, PhD ; Millman, Robin ; Alzouebi, Mymoona, FRCR ; Beesley, Sharon, FRCR ; Birtle, Alison J, MD ; Brock, Susannah, FRCR ; Cathomas, Richard, MD ; Chakraborti, Prabir, FRCR ; Chowdhury, Simon, MD ; Cook, Audrey, FRCR ; Elliott, Tony, PhD ; Gale, Joanna, DM ; Gibbs, Stephanie, FRCR ; Graham, John D, FRCP ; Hetherington, John, FRCS[Eng] ; Hughes, Robert, FRCR ; Laing, Robert, FRCR ; McKinna, Fiona, FRCR ; McLaren, Duncan B, FRCR, FRCP[Ed] ; O'Sullivan, Joe M, Prof ; Parikh, Omi, FRCR ; Peedell, Clive, FRCR ; Protheroe, Andrew, PhD ; Robinson, Angus J, FRCR ; Srihari, Narayanan, MD ; Srinivasan, Rajaguru, FRCR ; Staffurth, John, MD ; Sundar, Santhanam, FRCR ; Tolan, Shaun, MD ; Tsang, David, MCRP ; Wagstaff, John, Prof ; Parmar, Mahesh K B, Prof

The Lancet (British edition), 2016-03, Vol.387 (10024), p.1163-1177 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Cottu, P. ; D'Hondt, V. ; Dureau, S. ; Lerebours, F. ; Desmoulins, I. ; Heudel, P.-E. ; Duhoux, F.P. ; Levy, C. ; Mouret-Reynier, M.-A. ; Dalenc, F. ; Frenel, J.-S. ; Jouannaud, C. ; Venat-Bouvet, L. ; Nguyen, S. ; Ferrero, J.-M. ; Canon, J.-L. ; Grenier, J. ; Callens, C. ; Gentien, D. ; Lemonnier, J. ; Vincent-Salomon, A. ; Delaloge, S.

Annals of oncology, 2018-12, Vol.29 (12), p.2334-2340 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Formisano, Luigi ; Lu, Yao ; Servetto, Alberto ; Hanker, Ariella B ; Jansen, Valerie M ; Bauer, Joshua A ; Sudhan, Dhivya R ; Guerrero-Zotano, Angel L ; Croessmann, Sarah ; Guo, Yan ; Ericsson, Paula Gonzalez ; Lee, Kyung-Min ; Nixon, Mellissa J ; Schwarz, Luis J ; Sanders, Melinda E ; Dugger, Teresa C ; Cruz, Marcelo Rocha ; Behdad, Amir ; Cristofanilli, Massimo ; Bardia, Aditya ; O'Shaughnessy, Joyce ; Nagy, Rebecca J ; Lanman, Richard B ; Solovieff, Nadia ; He, Wei ; Miller, Michelle ; Su, Fei ; Shyr, Yu ; Mayer, Ingrid A ; Balko, Justin M ; Arteaga, Carlos L

Nature communications, 2019-03, Vol.10 (1), p.1373-1373, Article 1373 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5
Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5
Material Type:
Artigo 		Adicionar ao Meu Espaço

Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5

Dowsett, Mitch ; Sestak, Ivana ; Regan, Meredith M ; Dodson, Andrew ; Viale, Giuseppe ; Thürlimann, Beat ; Colleoni, Marco ; Cuzick, Jack

Journal of clinical oncology, 2018-07, Vol.36 (19), p.1941-1948 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Update in Adrenocortical Carcinoma
Update in Adrenocortical Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Update in Adrenocortical Carcinoma

Fassnacht, Martin ; Kroiss, Matthias ; Allolio, Bruno

The journal of clinical endocrinology and metabolism, 2013-12, Vol.98 (12), p.4551-4564 [Periódico revisado por pares]

Bethesda, MD: Endocrine Society

Texto completo disponível

Citações Citado por
8
Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer
Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

Hoyle, Alex P. ; Ali, Adnan ; James, Nicholas D. ; Cook, Adrian ; Parker, Christopher C. ; de Bono, Johann S. ; Attard, Gerhardt ; Chowdhury, Simon ; Cross, William R. ; Dearnaley, David P. ; Brawley, Christopher D. ; Gilson, Clare ; Ingleby, Fiona ; Gillessen, Silke ; Aebersold, Daniel M. ; Jones, Rob J. ; Matheson, David ; Millman, Robin ; Mason, Malcolm D. ; Ritchie, Alastair W.S. ; Russell, Martin ; Douis, Hassan ; Parmar, Mahesh K.B. ; Sydes, Matthew R. ; Clarke, Noel W.

European urology, 2019-12, Vol.76 (6), p.719-728 [Periódico revisado por pares]

Switzerland: Elsevier B.V

Texto completo disponível

Citações Citado por
9
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
Material Type:
Artigo 		Adicionar ao Meu Espaço

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Gnant, M. ; Mlineritsch, B. ; Stoeger, H. ; Luschin-Ebengreuth, G. ; Knauer, M. ; Moik, M. ; Jakesz, R. ; Seifert, M. ; Taucher, S. ; Bjelic-Radisic, V. ; Balic, M. ; Eidtmann, H. ; Eiermann, W. ; Steger, G. ; Kwasny, W. ; Dubsky, P. ; Selim, U. ; Fitzal, F. ; Hochreiner, G. ; Wette, V. ; Sevelda, P. ; Ploner, F. ; Bartsch, R. ; Fesl, C. ; Greil, R.

Annals of oncology, 2015-02, Vol.26 (2), p.313-320 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial
GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial

Leonard, R.C.F. ; Adamson, D.J.A. ; Bertelli, G. ; Mansi, J. ; Yellowlees, A. ; Dunlop, J. ; Thomas, G.A. ; Coleman, R.E. ; Anderson, R.A.

Annals of oncology, 2017-08, Vol.28 (8), p.1811-1816 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (3.852)
  2. Anais de Congresso  (3)
  3. magazinearticle  (2)
  4. Web Resources  (1)
  5. Newsletter Articles  (1)
  6. Livros  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1993  (13)
  2. 1993Até2000  (768)
  3. 2001Até2008  (1.267)
  4. 2009Até2017  (1.502)
  5. Após 2017  (310)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (3.378)
  2. Japonês  (533)
  3. Alemão  (83)
  4. Francês  (67)
  5. Russo  (58)
  6. Italiano  (30)
  7. Espanhol  (27)
  8. Chinês  (24)
  9. Húngaro  (16)
  10. Português  (15)
  11. Polonês  (10)
  12. Dinamarquês  (8)
  13. Norueguês  (5)
  14. Tcheco  (4)
  15. Romeno  (3)
  16. Serbian  (2)
  17. Holandês  (2)
  18. Finlandês  (2)
  19. Croatian  (2)
  20. Sueco  (2)
  21. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Skeel, R

Neste Assunto:

  1. Humans
  2. Science & Technology
  3. Antineoplastic Agents, Hormonal - Administration & Dosage
  4. Life Sciences & Biomedicine
  5. Female

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.